Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
32333 | 140 | 34.5 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
131 | 3 | HEMATOLOGY//HAEMOPHILIA//TRANSFUSION | 66936 |
2062 | 2 | VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//ENDOCAN | 5292 |
32333 | 1 | ENDOCAN//ENDOTHELIAL CELL SPECIFIC MOLECULE 1//ESM 1 | 140 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ENDOCAN | authKW | 15294713 | 56% | 89% | 79 |
2 | ENDOTHELIAL CELL SPECIFIC MOLECULE 1 | authKW | 3053555 | 10% | 100% | 14 |
3 | ESM 1 | authKW | 2849982 | 10% | 93% | 14 |
4 | ENDOTHELIAL CELL SPECIFIC MOLECULE | authKW | 436222 | 1% | 100% | 2 |
5 | AUSTRIAN FED MINIST DEF SPORTS | address | 218111 | 1% | 100% | 1 |
6 | BIOREACTOR CELLINE TM | authKW | 218111 | 1% | 100% | 1 |
7 | CDPC CLIN IMMUNOL | address | 218111 | 1% | 100% | 1 |
8 | ECM MVD | authKW | 218111 | 1% | 100% | 1 |
9 | ENDOCAN ESM 1 | authKW | 218111 | 1% | 100% | 1 |
10 | ENDOTHELIAL BIOMARKER | authKW | 218111 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 493 | 18% | 0% | 25 |
2 | Oncology | 138 | 18% | 0% | 25 |
3 | Medical Laboratory Technology | 116 | 5% | 0% | 7 |
4 | Cell Biology | 49 | 11% | 0% | 16 |
5 | Medicine, Research & Experimental | 37 | 7% | 0% | 10 |
6 | Critical Care Medicine | 23 | 3% | 0% | 4 |
7 | Pathology | 23 | 4% | 0% | 6 |
8 | Immunology | 22 | 8% | 0% | 11 |
9 | Hematology | 18 | 4% | 0% | 6 |
10 | Endocrinology & Metabolism | 13 | 5% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AUSTRIAN FED MINIST DEF SPORTS | 218111 | 1% | 100% | 1 |
2 | CDPC CLIN IMMUNOL | 218111 | 1% | 100% | 1 |
3 | INSERM BIOINGN CARDIOVASC U698 | 218111 | 1% | 100% | 1 |
4 | INT BIOL STRUCTUMR 5075 | 218111 | 1% | 100% | 1 |
5 | INTENS CARE ROUTE LENNIK | 218111 | 1% | 100% | 1 |
6 | ISTANBUL PUBL HLTH | 218111 | 1% | 100% | 1 |
7 | KYUNG HEE UNIV HOSP GANGDONGMED | 218111 | 1% | 100% | 1 |
8 | LUNGINNOV | 218111 | 1% | 100% | 1 |
9 | NEPHROL BIOMED | 218111 | 1% | 100% | 1 |
10 | PATHOL IMMUNOALLERG P | 218111 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANGIOLOGY | 5766 | 8% | 0% | 11 |
2 | MICROVASCULAR RESEARCH | 736 | 2% | 0% | 3 |
3 | JOURNAL OF VASCULAR RESEARCH | 722 | 1% | 0% | 2 |
4 | DIABETES & VASCULAR DISEASE RESEARCH | 539 | 1% | 0% | 1 |
5 | CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 534 | 1% | 0% | 1 |
6 | DISEASE MARKERS | 501 | 1% | 0% | 2 |
7 | PROGRESS IN TRANSPLANTATION | 481 | 1% | 0% | 1 |
8 | CYTOKINE | 440 | 2% | 0% | 3 |
9 | CLINICAL AND EXPERIMENTAL HYPERTENSION | 435 | 1% | 0% | 2 |
10 | JOURNAL OF CRITICAL CARE | 387 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENDOCAN | 15294713 | 56% | 89% | 79 | Search ENDOCAN | Search ENDOCAN |
2 | ENDOTHELIAL CELL SPECIFIC MOLECULE 1 | 3053555 | 10% | 100% | 14 | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE+1 | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE+1 |
3 | ESM 1 | 2849982 | 10% | 93% | 14 | Search ESM+1 | Search ESM+1 |
4 | ENDOTHELIAL CELL SPECIFIC MOLECULE | 436222 | 1% | 100% | 2 | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE |
5 | BIOREACTOR CELLINE TM | 218111 | 1% | 100% | 1 | Search BIOREACTOR+CELLINE+TM | Search BIOREACTOR+CELLINE+TM |
6 | ECM MVD | 218111 | 1% | 100% | 1 | Search ECM+MVD | Search ECM+MVD |
7 | ENDOCAN ESM 1 | 218111 | 1% | 100% | 1 | Search ENDOCAN+ESM+1 | Search ENDOCAN+ESM+1 |
8 | ENDOTHELIAL BIOMARKER | 218111 | 1% | 100% | 1 | Search ENDOTHELIAL+BIOMARKER | Search ENDOTHELIAL+BIOMARKER |
9 | ENDOTHELIAL CELL SPECIFIC MOLECULE 1 ESM 1 | 218111 | 1% | 100% | 1 | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE+1+ESM+1 | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE+1+ESM+1 |
10 | ENDOTHELIAL SPECIFIC MOLECULE 1 | 218111 | 1% | 100% | 1 | Search ENDOTHELIAL+SPECIFIC+MOLECULE+1 | Search ENDOTHELIAL+SPECIFIC+MOLECULE+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HUANG, X , CHEN, C , WANG, X , ZHANG, JY , REN, BH , MA, DW , XIA, L , XU, XY , XU, L , (2016) PROGNOSTIC VALUE OF ENDOCAN EXPRESSION IN CANCERS: EVIDENCE FROM META-ANALYSIS.ONCOTARGETS AND THERAPY. VOL. 9. ISSUE . P. 6297 -6304 | 27 | 82% | 0 |
2 | KALI, A , RATHAN, SKS , (2014) ENDOCAN: A NOVEL CIRCULATING PROTEOGLYCAN.INDIAN JOURNAL OF PHARMACOLOGY. VOL. 46. ISSUE 6. P. 579 -583 | 25 | 74% | 11 |
3 | BINGOL, Z , KOSE, M , PIHTILI, A , AKPINAR, T , TUKEK, T , KIYAN, E , (2016) SERUM ENDOTHELIAL CELL SPECIFIC MOLECULE-1 (ENDOCAN) LEVELS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA.BIOMARKERS IN MEDICINE. VOL. 10. ISSUE 2. P. 177 -184 | 20 | 83% | 0 |
4 | BALTA, S , MIKHAILIDIS, DP , DEMIRKOL, S , OZTURK, C , CELIK, T , IYISOY, A , (2015) ENDOCAN: A NOVEL INFLAMMATORY INDICATOR IN CARDIOVASCULAR DISEASE?.ATHEROSCLEROSIS. VOL. 243. ISSUE 1. P. 339 -343 | 20 | 63% | 14 |
5 | ZHAO, WY , SUN, M , LI, SQ , WANG, Y , LIU, JG , (2014) BIOLOGICAL AND CLINICAL IMPLICATIONS OF ENDOCAN IN GASTRIC CANCER.TUMOR BIOLOGY. VOL. 35. ISSUE 10. P. 10043 -10049 | 19 | 79% | 4 |
6 | HENTSCHKE, MR , LUCAS, LS , MISTRY, HD , DA COSTA, BEP , POLI-DE-FIGUEIREDO, CE , (2015) ENDOCAN-1 CONCENTRATIONS IN MATERNAL AND FETAL PLASMA AND PLACENTAE IN PRE-ECLAMPSIA IN THE THIRD TRIMESTER OF PREGNANCY.CYTOKINE. VOL. 74. ISSUE 1. P. 152 -156 | 19 | 73% | 1 |
7 | KUNDI, H , BALUN, A , CICEKCIOGLU, H , KARAYIGIT, O , TOPCUOGLU, C , KILINCKAYA, MF , KIZILTUNC, E , CETIN, M , ORNEK, E , (2017) ADMISSION ENDOCAN LEVEL MAY BE A USEFUL PREDICTOR FOR IN-HOSPITAL MORTALITY AND CORONARY SEVERITY INDEX IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION.ANGIOLOGY. VOL. 68. ISSUE 1. P. 46 -51 | 13 | 59% | 1 |
8 | KECHAGIA, M , PAPASSOTIRIOU, I , GOURGOULIANIS, KI , (2016) ENDOCAN AND THE RESPIRATORY SYSTEM: A REVIEW.INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. VOL. 11. ISSUE . P. 3179 -3187 | 32 | 40% | 0 |
9 | ARMAN, Y , AKPINAR, TS , KOSE, M , EMET, S , YURUYEN, G , AKARSU, M , OZCAN, M , YEGIT, O , CAKMAK, R , ALTUN, O , ET AL (2016) EFFECT OF GLYCEMIC REGULATION ON ENDOCAN LEVELS IN PATIENTS WITH DIABETES: A PRELIMINARY STUDY.ANGIOLOGY. VOL. 67. ISSUE 3. P. 239 -244 | 13 | 65% | 7 |
10 | ATUKEREN, P , KUNBAZ, A , TURK, O , KEMERDERE, R , ULU, MO , INANIR, NT , TANRIVERDI, T , (2016) EXPRESSIONS OF ENDOCAN IN PATIENTS WITH MENINGIOMAS AND GLIOMAS.DISEASE MARKERS. VOL. . ISSUE . P. - | 13 | 93% | 0 |
Classes with closest relation at Level 1 |